Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 1/2012

01-02-2012

Invited commentary: the incidentally discovered solid pancreatic mass: imaging and clinical observations

Author: Chusilp Charnsangavej

Published in: Abdominal Radiology | Issue 1/2012

Login to get access

Excerpt

The rapid growth of usage of medical imaging technology and the improvement in image resolution over the past two decades have resulted in the new diagnosis known as an “incidentaloma”. An incidentaloma is defined as an incidentally discovered mass or lesion, detected by CT, MRI, or other imaging modality performed for an unrelated reason. It has become such an important issue in clinical practice that the American College of Radiology formed the Incidental Findings Committee to address the issue of “incidentaloma” on abdominal CT and to provide guidelines on how to report and manage the condition [1]. …
Literature
1.
Berland LL, Silverman SG, Gore RM, et al. (2010) Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol 7:754–773.PubMedCrossRef
2.
Goodman M, Willmann JK, Jeffrey B (2011) The incidentally discovered solid pancreatic masses: imaging and clinical observations. Abdom Imaging 37 (in this issue). doi:10.​1007/​s00261-011-9720-2.
3.
Sachs T, Pratt WB, Callery MP, Vollmer CM Jr (2009) The incidental asymptomatic pancreatic lesion: nuisance or threat? J Gastrointest Surg 13:405–415.PubMedCrossRef
4.
Bruzoni M, Johnston E, Sasson AR (2008) Pancreatic incidentalomas: clinical and pathologic spectrum. Am J Surg 195:329–332.PubMedCrossRef
5.
Winter JM, Cameron JL, Lillemoe KD, et al. (2006) Periampullary and pancreatic incidentaloma: a single institution’s experience with an increasingly common diagnosis. Ann Surg 243:673–683.PubMedCrossRef
6.
Lahat G, Ben Haim M, Nachmany I, et al. (2009) Pancreatic incidentalomas: high rate of potentially malignant tumors. J Am Coll Surg 209:313–319.PubMedCrossRef
Metadata
Title
Invited commentary: the incidentally discovered solid pancreatic mass: imaging and clinical observations
Author
Chusilp Charnsangavej
Publication date
01-02-2012
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 1/2012
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-011-9813-y

Other articles of this Issue 1/2012

Abdominal Radiology 1/2012 Go to the issue

OriginalPaper

MR findings of lithium-related kidney disease: preliminary observations in four patients

OriginalPaper

Common and unusual diseases involving the iliopsoas muscle compartment: spectrum of cross-sectional imaging findings

OriginalPaper

Diagnostic yield of capsule endoscopy for gastric diseases

OriginalPaper

Contrast-enhanced ultrasound in abdominal imaging

Pictorial Essay

Relapse of Crohn’s disease following ileal pouch-anal anastomosis: MDCT and MR features

OriginalPaper

Diffusion-weighted MRI of focal cystic pancreatic lesions at 3.0-Tesla: preliminary results
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits